Amsurg Corp. (NASDAQ:AMSG) shares rose 4.7% on Thursday . The stock traded as high as $65.65 and last traded at $65.57, with a volume of 993,750 shares. The stock had previously closed at $62.60.

AMSG has been the subject of several recent analyst reports. Jefferies Group reissued a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Robert W. Baird reissued a “buy” rating on shares of Amsurg Corp. in a report on Thursday, June 16th. Zacks Investment Research raised shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a report on Monday, July 11th. Mizuho raised their price objective on shares of Amsurg Corp. from $84.00 to $90.00 and gave the stock a “buy” rating in a report on Wednesday, May 4th. Finally, Goldman Sachs Group Inc. reissued a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Amsurg Corp. currently has an average rating of “Buy” and an average target price of $93.91.

The firm’s 50 day moving average is $74.15 and its 200 day moving average is $74.31. The stock has a market cap of $3.52 billion and a PE ratio of 19.45.

Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. During the same quarter in the previous year, the firm posted $0.97 earnings per share. The firm earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp.’s quarterly revenue was up 21.5% compared to the same quarter last year. Analysts predict that Amsurg Corp. will post $4.33 earnings per share for the current year.

Other hedge funds have recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its stake in shares of Amsurg Corp. by 3.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,994,029 shares of the company’s stock worth $227,552,000 after buying an additional 92,088 shares during the last quarter. BNP Paribas Arbitrage SA boosted its position in Amsurg Corp. by 1,872.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 194,790 shares of the company’s stock valued at $14,804,000 after buying an additional 184,912 shares during the last quarter. Morgan Stanley boosted its position in Amsurg Corp. by 115.7% in the fourth quarter. Morgan Stanley now owns 182,105 shares of the company’s stock valued at $13,840,000 after buying an additional 97,682 shares during the last quarter. Redwood Investments LLC boosted its position in Amsurg Corp. by 20.3% in the fourth quarter. Redwood Investments LLC now owns 28,011 shares of the company’s stock valued at $2,129,000 after buying an additional 4,732 shares during the last quarter. Finally, US Bancorp DE boosted its position in Amsurg Corp. by 30.5% in the fourth quarter. US Bancorp DE now owns 23,339 shares of the company’s stock valued at $1,774,000 after buying an additional 5,461 shares during the last quarter.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.